Literature DB >> 25591061

Varieties of standard-of-care treatment randomized trials: ethical implications.

Scott Y H Kim1, Franklin G Miller1.   

Abstract

Mesh：

Year:  2015        PMID： 25591061     DOI： 10.1001/jama.2014.18528

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  16 in total

Review 1.  Predictable and SuStainable Implementation of National Cardiovascular Registries (PASSION) infrastructure: A think tank report from Medical Device Epidemiological Network Initiative (MDEpiNet).

Authors:  Emily P Zeitler; Sana M Al-Khatib; Joseph P Drozda; Larry G Kessler; Ajay J Kirtane; David F Kong; John Laschinger; Danica Marinac-Dabic; Marie-Claude Morice; Terrie Reed; Art Sedrakyan; Kenneth M Stein; James Tcheng; Mitchell W Krucoff
Journal:  Am Heart J       Date:  2015-07-30       Impact factor: 4.749

2.  Prone positioning and neuromuscular blocking agents are part of standard care in severe ARDS patients: no.

Authors:  Niall D Ferguson; B Taylor Thompson
Journal:  Intensive Care Med       Date:  2015-09-23       Impact factor: 17.440

3.  Ethics and practice of Trials within Cohorts: An emerging pragmatic trial design.

Authors:  Scott Yh Kim; James Flory; Clare Relton
Journal:  Clin Trials       Date:  2017-12-11       Impact factor: 2.486

4.  The Food and Drug Administration and pragmatic clinical trials of marketed medical products.

Authors:  Monique L Anderson; Joseph Griffin; Sara F Goldkind; Emily P Zeitler; Liz Wing; Sana M Al-Khatib; Rachel E Sherman
Journal:  Clin Trials       Date:  2015-09-15       Impact factor: 2.486

5.  Harms, benefits, and the nature of interventions in pragmatic clinical trials.

Authors:  Joseph Ali; Joseph E Andrews; Carol P Somkin; C Egla Rabinovich
Journal:  Clin Trials       Date:  2015-09-15       Impact factor: 2.486

6.  A prospective multi-centre, randomized study comparing the addition of tapering dexamethasone to other standard of care therapies for taxane-associated pain syndrome (TAPS) in breast cancer patients.

Authors:  Mark Clemons; Demetrios Simos; Marta Sienkiewicz; Terry Ng; Labib Zibdawi; Bassam Basulaiman; Arif Awan; Dean Fergusson; Lisa Vandermeer; Deanna Saunders; Brian Hutton; Eitan Amir
Journal:  Support Care Cancer       Date:  2021-03-19       Impact factor: 3.603

7.  Patient and Physician Views about Protocolized Dialysis Treatment in Randomized Trials and Clinical Care.

Authors:  Ashley Kraybill; Laura M Dember; Steven Joffe; Jason Karlawish; Susan S Ellenberg; Vanessa Madden; Scott D Halpern
Journal:  AJOB Empir Bioeth       Date:  2015-10-23

8.  A framework for analysis of research risks and benefits to participants in standard of care pragmatic clinical trials.

Authors:  Stephanie C Chen; Scott Yh Kim
Journal:  Clin Trials       Date:  2016-06-30       Impact factor: 2.486

9.  Ethical complexities in standard of care randomized trials: A case study of morning versus nighttime dosing of blood pressure drugs.

Authors:  Scott Y H Kim; Franklin G Miller
Journal:  Clin Trials       Date:  2015-09-22       Impact factor: 2.486

10.  Innovative Practice, Clinical Research, and the Ethical Advancement of Medicine.

Authors:  Jake Earl
Journal:  Am J Bioeth       Date:  2019-06       Impact factor: 11.229
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.